Zacks Investment Research

Shares of Gilead Sciences (NASDAQ:GILD) gained 3.76% on Mar 13 as, per reports, its experimental candidate, remdesivir, showed promising results in 14 Americans hospitalized in Japan for the...

Unit (UNT) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to earnings of $0.27 per share a year ago. These figures are adjusted...

For investors looking for momentum, Invesco DB US Dollar Index Bullish Fund UUP is probably a suitable pick. The fund just hit a 52-week high — up roughly 11.9% from its 52-week low of...

CorMedix (CRMD) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to earnings of $0.10 per share a year ago. These figures are...

Great Lakes Dredge & Dock (GLDD) closed at $7.47 in the latest trading session, marking a -1.58% move from the prior day. This change was narrower than the S&P 500's 11.98% loss on the day....

AGNC Investment (AGNC) closed at $11.81 in the latest trading session, marking a -1.67% move from the prior day. This change was narrower than the S&P 500's 11.98% loss on the day. Meanwhile, the...

CV Sciences, Inc. (CVSI) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.03 per share a year ago. These...

COUPA SOFTWARE (COUP) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago. These...

The coronavirus outbreak has spread to 158 countries and territories, with 171,881 confirmed cases and the death toll rising to 6,526. The above-mentioned figures justify the terming of the outbreak...

HealthEquity (HQY) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.27 per share a year ago. These figures...

AVEO Pharmaceuticals (AVEO) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.30 per share a year ago. These figures...

Kindred Biosciences (KIN) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.46 per share a year ago. These figures...

The Federal Reserve just spent its remaining basis points and is now out of monetary bullets. In times of fear and panic, monetary policy changes will do little for short-term anxieties. The markets...

On today’s episode of Full Court Finance here at Zacks, Ben Rains dives into the continued coronavirus-based market downturn that caused another trading halt on Monday. We then take a look at...

The Federal Reserve made an unprecedented emergency rate cut on Sunday that dropped its benchmark Fed Funds rate by 100 basis points, 3 days before the FOMC was set to meet. Jerome Powell and his...

Just as the coronavirus-induced global market selloffs started, the pain for already-struggling U.S. small-cap stocks aggravated. U.S. Small-cap ETF iShares Russell 2000 ETF IWM was off 28.8% in the...